Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles

European Respiratory Journal

Volumn 35, Issue 1, 2010, Pages 176-185

  Decologne, N ^a   Wettstein, G ^a   Kolb, M ^c   Margetts, P ^c   Garrido, C ^a   Camus, P ^a,b   Bonniaud, P ^a,b  

^a Chu   (France)

^b HÔPITAL DU BOCAGE   (France)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Drug induced pneumonitis; Epithelial to mesenchymal transition; Idiopathic pulmonary fibrosis; Myofibroblast; Pleura; Transforming growth factor

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE; CARBON; CARBON BLACK 101; CIGARETTE SMOKE; MATRIX PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FIBROBLAST; LUNG ALVEOLUS; LUNG FIBROSIS; MESOTHELIUM CELL; MORPHOMETRICS; MOUSE; MYOFIBROBLAST; NONHUMAN; PLEURA; PLEURA CAVITY; PLEURA MESOTHELIAL CELL; PLEURAL FIBROSIS; PRIORITY JOURNAL; SUBPLEURAL FIBROSIS; THORACIC CAVITY;

ANIMALS; BLEOMYCIN; EPITHELIAL CELLS; FEMALE; FIBROSIS; MICE; PLEURA; SOOT;

EID: 75149173556     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00181808     Document Type: Article

References (34)

1. Jantz MA, Antony VB. Pleural fibrosis. Clin Chest Med 2006; 27: 181-191.
2. Azoulay E, Paugam B, Heymann MF, et al. Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J 1999; 14: 971-973.
3. Becker CD, Gil J, Padilla ML. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?Mod Pathol 2008; 21: 784-787.
4. Frankel SK, Cool CD, Lynch DA, et al. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007-2013.
5. Lee YC, Light RW. Management of malignant pleural effusions. Respirology 2004; 9: 148-156.
6. Light RW. Talc for pleurodesis? Chest 2002; 122: 1506-1508.
7. Geiser T. Idiopathic pulmonary fibrosis: a disorder of alveolar wound repair? Swiss Med Wkly 2003; 133: 405-411.
8. Decologne N, Kolb M, Margetts PJ, et al. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 2007; 179: 6043-6051.
9. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 1986; 133: 321-340.
10. Foucher P, Camus P, GEPPI. Pneumotox online. The drug-induced lung diseases. www.pneumotox.com Date last updated: September 2009.
11. Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Eur Respir J 2001; 18: 402-419.
12. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242-248.
13. Lower EE, Strohofer S, Baughman RP. Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide. Am J Med Sci 1988; 295: 193-197.
14. Cisneros-Lira J, Gaxiola M, Ramos C, et al. Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs. Am J Physiol 2003; 285: L949-L956.
15. Valente P, Forastiere F, Bacosi A, et al. Exposure to fine and ultrafine particles from secondhand smoke in public places before and after the smoking ban, Italy 2005. Tob Control 2007; 16: 312-317.
16. Holt PF. Translocation of inhaled dust to the pleura. Environ Res 1983; 31: 212-220.
17. Marchi E, Vargas FS, Acencio MM, et al. Pleurodesis: a novel experimental model. Respirology 2007; 12: 500-504.
18. Kakugawa T, Mukae H, Hayashi T, et al. Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. Eur Respir J 2004; 24: 57-65.
19. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
20. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008; 40: 362-382.
21. Borzone G, Moreno R, Urrea R, et al. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 163: 1648-1653.
22. Jones AW, Reeve NL. Ultrastructural study of bleomycin-induced pulmonary changes in mice. J Pathhol 1978; 124: 227-233.
23. Lee YC, Baumann MH, Maskell NA, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003; 124: 2229-2238.
24. Lee YC, Lane KB, Parker RE, et al. Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000; 55: 1058-1062.
25. Sekhon H, Wright J, Churg A. Effects of cigarette smoke and asbestos on airway, vascular and mesothelial cell proliferation. Int J Exp Pathol 1995; 76: 411-418.
26. Donaldson K, Aitken R, Tran L, et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006; 92: 5-22.
27. Andre E, Stoeger T, Takenaka S, et al. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. Eur Respir J 2006; 28: 275-285.
28. Donaldson K, Stone V, Tran CL, et al. Nanotoxicology. Occup Environ Med 2004; 61: 727-728.
29. Beattie J, Knox JF. Studies of mineral content and particle size distribution in the lungs of asbestos textile workers. In: Inhaled Particles and Vapours. CN Davis, ed. London, Pergamon Press, 1961: pp. 419-432.
30. Adamson IY, Prieditis HL. Response of mouse lung to carbon deposition during injury and repair. Environ Health Perspect 1995; 103: 72-76.
31. Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol 2007; 293: L525-L534.
32. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002; 7: 171-191.
33. Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006; 174: 654-658.
34. Liu W, Ernst JD, Broaddus VC. Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am J Respir Cell Mol Biol 2000; 23: 371-378.